Ann: CEO Succession, page-90

And for contrast, this is the calibre of Board members on MSB.

The latest addition in today's Ann?

" Mesoblast Limited(ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases,today announced that Philip R. Krause, M.D. has joined its Board of Directors. Dr. Krause was for the past decade Deputy Director, Office of Vaccines Research and Review (OVRR) at the US Food andDrug Administration (FDA)’s Center for Biologics Evaluation and Research (CBER). Dr. Krause is currently Chair of the World Health Organization COVID Vaccines Research Expert Group, and most recently he shared responsibility for regulatory authorizations of COVID-19 vaccines in the US."

Yet ADO had a blogger with experience running his own portfolio. Removing him was overdue, but no doubt met with the kind of deep seated resentment that would put factions in the ALP in the shade.

You don't stack the Board with mates. Appointments must be made on calibre and personal likes and dislikes kept to an absolute minimum.

But in his wisdom we get ADO's main head kicker aka. shareholder activist telling me MSB is a dud! ROFL.

No mate, it just takes patience and understanding. Qualities you quite obviously lack.